Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

Safety Fears Slow Prescription Drug Growth

Posted by Jane Akre
Thursday, January 08, 2009 11:13 AM EST
Category: Major Medical, Protecting Your Family
Tags: FDA and Prescription Drugs, Dangerous Drugs, Black Box Warnings, Antidepressants

Consumers choosing generic drugs are leading the reduction in overall spending.

LEARN MORE

 

IMAGE SOURCE:© iStockphoto/ pouring pills/ author: VisualField

 

Prescription drugs still fall in the plus column as a category for consumer spending, but last year retail spending on prescription slowed to the lowest rate in more than 40 years.

The Centers for Medicare and Medicaid Services reports that consumers are increasingly turning to generics to fill their drug needs largely because of a “growing concerns for drug safety.”   

Last year the Food and Drug Administration (FDA) was given new authority to issue the most serious warnings that a drug can lead to death – a "black box" warning.

There were 68 “black box” warnings issued by the FDAin 2007, compared to 58 warnings in 2006, and 21 issued in 2003, according to the report. 

The agency was given the authority to mandate drug warnings by the Amendments Act of 2007. Previously the FDA could only request the manufacturer comply.

In the first demonstration of its new authority in 2007, the FDA ordered makers of older antipsychotics, such as thorazine and prolixin, to carry a new black box warning alerting physicians of their dangers.

Safety concerns may have added to the drug consumption slowdown – 4.9 percent or $228 billion. Drug spending peaked in 1999 at 18.8 percent, and slowed slightly in 2006 to 8.6 percent.

Older drugs that have generic versions are falling into favor because a) they’ve been around longer so have a more reliable safety record and b) they’re cheaper because patents have expired on the more expensive blockbuster brand-name drugs.

Meanwhile, spending for other sectors of healthcare such as payments to hospitals, grew slightly last year, while the compensation for physician services declined due to a reduction in payments for Medicare patients authorized by Congress.

Whether consumers will continue to opt for generics or fewer drugs in general is a future uncertainty that will impact our national spending on health.  

Despite slowed growth, health care costs continue to risse at an unsustainable rate of $2.2 trillion in 2007 or 16.2 percent of the gross domestic product, which is a record.  #


No Comments

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes